UNC researchers and colleagues are the first to develop a mouse model that more accurately reflects human disease symptoms; they found a single gene crucial for disease severity.
UNC TV reporter Daniel Lane stopped by to interview Eric Ubil, PhD, who as a graduate student studied how fibroblasts that form scar tissue can be turned into endothelial cells to help repair the heart after a heart attack.
Hypertonic saline, developed into an effective treatment at UNC School of Medicine in collaboration with Australian researchers, has become a proven therapy for thousands of people with cystic fibrosis.
UNC Lineberger Comprehensive Cancer Center and the UNC Institute for Global Health & Infectious Diseases have received a $3.7 million grant from the National Cancer Institute (NCI) to study the growing worldwide cancer problem and expand the University’s efforts in Malawi to study and treat HIV-associated cancers.
The research, led by Andrew C. Dudley, PhD, has implications for developing cancer drugs that target blood vessels that feed tumors.
Roth’s research to create innovative tools for neuroscientists and discover potential targets for therapeutics has earned him one of the highest honors in the field of medicine.
The partnership aims to create new drugs to help patients with lung diseases clear mucus, a major roadblock to normal respiratory health.
The collaboration of Mark Zylka, PhD, and Ben Philpot, PhD, led to a new discovery about potential underlying causes of autism
In cell lines, scientists at the joint UNC-NC State biomedical engineering program have shown that the new nano particles can stealthily enter cancer cells and release a known drug to attack tumors from the inside.
By bumping up the levels of a well-known protein in the heart, UNC researchers have found a new way to generate more blood vessels following a heart attack.
The National Institutes of Health recently awarded researchers from the UNC School of Medicine and the UNC Gillings School of Public Health more than $2 million to study the effects of physical activity food labeling on consumer food choices and exercise.
Graduate student Ellen Perkowski created a new tool to study how tuberculosis survives, thrives, and escapes our immune system defenses.
UNC has received a $1.8 million NIH grant to expand training programs for graduate students and postdoctoral trainees who seek a career inside or outside academia.
Evan S. Dellon, MD, MPH, will lead UNC’s role in the new consortium.
Brian Strahl, PhD, and his band of biochemists unravel the complicated mysteries of the epigenetic code to find a culprit in cancer development.
Five winners of a not so famous award based at UNC have gone on to win the highest honor in medicine.
The cries of babies whose mothers used cocaine during pregnancy have increased amounts of “hyperphonation,” a new study finds.
Led by Bryan L. Roth, MD, PhD, three UNC labs will develop the next generation neuroscience tool-kit to accelerate novel treatments for neuropsychiatric and a host of other diseases.
William A. Rutala, PhD, Director of Hospital Epidemiology, and David J. Weber, MD, MPH, Medical Director of Hospital Epidemiology and Associate Chief Medical Officer of UNC Health Care, discuss disinfection of gastrointestinal endoscopes in the Oct. 8, 2014 issue of the Journal of the American Medical Assocation.
The University of North Carolina at Chapel Hill has been awarded a five-year, $6.25 million renewal grant to continue its work as part of the National Institutes of Health’s Rare Diseases Clinical Research Network (RDCRN).